{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:42:48Z","timestamp":1787877768309,"version":"build-2784847793"},"reference-count":184,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Chronic kidney disease (CKD) and cardiovascular disease are bidirectionally linked, with metabolic reprogramming as a central pathophysiological nexus. This review examines metabolic disturbances underlying CKD\u2013CVD comorbidity, including energy metabolism disorders, mitochondrial dysfunction, lipid and glucose dysregulation, and mineral metabolism abnormalities. The gut microbiota\u2013metabolic axis contributes through depletion of short-chain fatty acids, accumulation of trimethylamine N-oxide, and production of uremic toxins. These changes compromise intestinal barrier integrity and sustain systemic inflammation. Downstream consequences include oxidative stress, NLRP3 inflammasome activation, cardiac and renal fibrosis, vascular calcification, and endothelial dysfunction. We critically distinguish validated interventions from speculative strategies. SGLT2 inhibitors and GLP-1 receptor agonists have established cardiorenal protection in large randomized trials, with effects extending beyond glycemic control. By contrast, gut microbiota modulation, mitochondria-targeted therapies, and several anti-inflammatory and anti-fibrotic strategies remain at the preclinical or early-phase clinical stage, and a number of mechanistically attractive interventions have failed in confirmatory trials. We also outline areas of contradictory evidence and unresolved questions. Future directions include multi-omics integration, metabolic phenotype-based stratification, and rational drug development targeting central metabolic nodes. The review provides mechanistic insights into metabolic\u2013immune\u2013inflammatory crosstalk in CKD\u2013CVD and highlights priorities for translation.<\/jats:p>","DOI":"10.3389\/fphar.2026.1801502","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T07:22:40Z","timestamp":1783581760000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic reprogramming in chronic kidney disease-cardiovascular disease comorbidity: from molecular mechanisms to therapeutic strategies"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiang-jing","family":"Chai","sequence":"first","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gong","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-yu","family":"Min","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]},{"name":"Postdoctoral Research Station, China Academy of Chinese Medical Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Guan","sequence":"additional","affiliation":[{"name":"Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]},{"name":"Affiliated Hospital of Liaoning University of Traditional Chinese Medicine","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.3390\/biomedicines11113033","article-title":"An overview of chronic kidney disease pathophysiology: the impact of gut dysbiosis and oral disease","volume":"11","author":"Altamura","year":"2023","journal-title":"Biomedicines"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e18991","DOI":"10.1016\/j.heliyon.2023.e18991","article-title":"Chronic kidney disease and gut microbiota","volume":"9","author":"Amini Khiabani","year":"2023","journal-title":"Heliyon"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/ki.2012.440","article-title":"The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease","volume":"83","author":"Anders","year":"2013","journal-title":"Kidney Int."},{"key":"B4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2011.07.001","article-title":"Pericytes: developmental, physiological, and pathological perspectives, problems, and promises","volume":"21","author":"Armulik","year":"2011","journal-title":"Dev. Cell."},{"key":"B5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1016\/s0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.amjcard.2013.11.070","article-title":"The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials","volume":"113","author":"Banon","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1139\/y08-059","article-title":"Endothelin: 20 years from discovery to therapy","volume":"86","author":"Barton","year":"2008","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrneph.2017.107","article-title":"Mitochondrial energetics in the kidney","volume":"13","author":"Bhargava","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.2337\/diabetes.50.12.2792","article-title":"Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB","volume":"50","author":"Bierhaus","year":"2001","journal-title":"Diabetes"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2842S","DOI":"10.1093\/jn\/134.10.2842S","article-title":"Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the \u201cL-arginine paradox\u201d and acts as a novel cardiovascular risk factor","volume":"134","author":"B\u00f6ger","year":"2004","journal-title":"J. Nutr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1161\/circresaha.110.234278","article-title":"The regulation of valvular and vascular sclerosis by osteogenic morphogens","volume":"109","author":"Bostr\u00f6m","year":"2011","journal-title":"Circ. Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2018.02.009","article-title":"Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: the CRIC study","volume":"271","author":"Bundy","year":"2018","journal-title":"Atherosclerosis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e133817","DOI":"10.1172\/jci.insight.133817","article-title":"Gut-derived uremic toxin handling in vivo requires OAT-Mediated tubular secretion in chronic kidney disease","volume":"5","author":"Bush","year":"2020","journal-title":"JCI Insight"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.3390\/biomedicines11113063","article-title":"Gut-kidney-heart: a novel trilogy","volume":"11","author":"Caldarelli","year":"2023","journal-title":"Biomedicines"},{"key":"B19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.febslet.2007.11.051","article-title":"TNF-Alpha and adipocyte biology","volume":"582","author":"Cawthorn","year":"2008","journal-title":"FEBS Lett."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/sj.ki.5002729","article-title":"Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review","volume":"73","author":"Coca","year":"2008","journal-title":"Kidney Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1016\/s0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of Statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1089\/ars.2010.3522","article-title":"Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants","volume":"15","author":"Cook-Mills","year":"2011","journal-title":"Antioxid. Redox Signal"},{"key":"B23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1242\/dmm.004077","article-title":"Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer","volume":"4","author":"Cox","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"B24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur. Heart J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"H15","DOI":"10.1152\/ajpheart.00459.2014","article-title":"Angiotensin II blockade: how its molecular targets May signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition","volume":"309","author":"de Cavanagh","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1161\/circulationaha.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"B27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1172\/jci110067","article-title":"Insulin resistance in uremia","volume":"67","author":"DeFronzo","year":"1981","journal-title":"J. Clin. Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-Beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"Interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.tcb.2022.03.012","article-title":"The multifaceted role of kidney tubule mitochondrial dysfunction in kidney disease development","volume":"32","author":"Doke","year":"2022","journal-title":"Trends Cell. Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ncpendmet0894","article-title":"The pathogenesis of diabetic nephropathy","volume":"4","author":"Dronavalli","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"B32","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like Peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell. Metab."},{"key":"B33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1124\/dmd.121.000415","article-title":"Pregnane X receptor and the gut-liver axis: a recent update","volume":"50","author":"Dutta","year":"2022","journal-title":"Drug Metab. Dispos."},{"key":"B34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrneph.2015.214","article-title":"Mitochondrial dysfunction in inherited renal disease and acute kidney injury","volume":"12","author":"Emma","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/jci46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B36","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/biom10020347","article-title":"The role of PGC-1\u03b1 and mitochondrial biogenesis in kidney diseases","volume":"10","author":"Fontecha-Barriuso","year":"2020","journal-title":"Biomolecules"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1161\/circulationaha.105.602532","article-title":"Endothelial nitric oxide synthase in vascular disease: from marvel to menace","volume":"113","author":"F\u00f6rstermann","year":"2006","journal-title":"Circulation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1161\/circresaha.116.309326","article-title":"Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis","volume":"120","author":"F\u00f6rstermann","year":"2017","journal-title":"Circ. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/s0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/ndt\/gfz182","article-title":"Sudden cardiac death in dialysis patients: different causes and management strategies","volume":"36","author":"Genovesi","year":"2021","journal-title":"Nephrol. Dial. Transpl."},{"key":"B41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3390\/nu13051580","article-title":"Sugar or fat? Renal tubular metabolism reviewed in health and disease","volume":"13","author":"Gewin","year":"2021","journal-title":"Nutrients"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1097\/01.Asn.0000145894.57533.C4","article-title":"Vascular calcification mechanisms","volume":"15","author":"Giachelli","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"C525","DOI":"10.1152\/ajpcell.00143.2024","article-title":"Mechanisms of heart failure and chronic kidney disease protection by SGLT2 inhibitors in nondiabetic conditions","volume":"327","author":"Girardi","year":"2024","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/s0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2215\/cjn.01580210","article-title":"Effect of allopurinol in chronic kidney disease progression and cardiovascular risk","volume":"5","author":"Goicoechea","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"e160437","DOI":"10.1172\/jci.insight.160437","article-title":"The kidney drug transporter OAT1 regulates gut microbiome-dependent host metabolism","volume":"8","author":"Granados","year":"2023","journal-title":"JCI Insight"},{"key":"B49","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/nm.3901","article-title":"Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease","volume":"21","author":"Grande","year":"2015","journal-title":"Nat. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1161\/cir.0000000000000625","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American college of cardiology\/american heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"16684","DOI":"10.1021\/bi051908a","article-title":"Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction","volume":"44","author":"Han","year":"2005","journal-title":"Biochemistry"},{"key":"B52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1194\/jlr.P040501","article-title":"Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy","volume":"55","author":"Herman-Edelstein","year":"2014","journal-title":"J. Lipid Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"e70050","DOI":"10.1002\/mnfr.70050","article-title":"Mediterranean diet modulates gene expression of cholesterol efflux receptors in high-risk cardiovascular patients","volume":"69","author":"Hernando-Redondo","year":"2025","journal-title":"Mol. Nutr. Food Res."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00204-023-03510-7","article-title":"Metabolic impact of genetic and chemical ADP\/ATP carrier inhibition in renal proximal tubule epithelial cells","volume":"97","author":"Hoogstraten","year":"2023","journal-title":"Arch. Toxicol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1126\/science.271.5249.665","article-title":"IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance","volume":"271","author":"Hotamisligil","year":"1996","journal-title":"Science"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.kint.2019.02.022","article-title":"Heart failure in chronic kidney disease: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"95","author":"House","year":"2019","journal-title":"Kidney Int."},{"key":"B59","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int."},{"key":"B60","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1681\/asn.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"837500","DOI":"10.3389\/fphar.2022.837500","article-title":"The intestinal microbiota and metabolites in the gut-kidney-heart axis of chronic kidney disease","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"804189","DOI":"10.3389\/fphar.2022.804189","article-title":"Identifying drug-induced liver injury associated with inflammation-drug and drug-drug interactions in pharmacologic treatments for COVID-19 by bioinformatics and system biology analyses: the role of pregnane X receptor","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI clinical practice guideline for nutrition in CKD: 2020 update","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int."},{"key":"B65","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1053\/j.ajkd.2012.07.021","article-title":"Uric acid as a target of therapy in CKD","volume":"61","author":"Jalal","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"B66","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B67","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat. Med."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","article-title":"Targeting Interleukin-6 signaling in clinic","volume":"50","author":"Kang","year":"2019","journal-title":"Immunity"},{"key":"B69","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/01.res.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circ. Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s42255-019-0161-5","article-title":"NAD(+) homeostasis in health and disease","volume":"2","author":"Katsyuba","year":"2020","journal-title":"Nat. Metab."},{"key":"B71","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int."},{"key":"B72","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archinte.164.6.659","article-title":"Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization","volume":"164","author":"Keith","year":"2004","journal-title":"Arch. Intern Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"12394","DOI":"10.3390\/ijms222212394","article-title":"Uric acid in inflammation and the pathogenesis of atherosclerosis","volume":"22","author":"Kimura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1681\/asn.2012030254","article-title":"Protein carbamylation predicts mortality in ESRD","volume":"24","author":"Koeth","year":"","journal-title":"J. Am. Soc. Nephrol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"","journal-title":"Nat. Med."},{"key":"B76","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1681\/asn.2012050503","article-title":"-Cresyl sulfate promotes insulin resistance associated with CKD","volume":"24","author":"Koppe","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/ki.2011.355","article-title":"High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease","volume":"81","author":"Krishnamurthy","year":"2012","journal-title":"Kidney Int."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2337\/dc18-0165","article-title":"Effect of empagliflozin on liver fat in patients with type 2 diabetes and nonalcoholic fatty liver disease: a randomized controlled trial (E-LIFT trial)","volume":"41","author":"Kuchay","year":"2018","journal-title":"Diabetes Care"},{"key":"B79","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1053\/j.jrn.2022.12.004","article-title":"Targeting the gut microbiota in kidney disease: the future in renal nutrition and metabolism","volume":"33","author":"Lambert","year":"2023","journal-title":"J. Ren. Nutr."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.7150\/ijbs.7.1056","article-title":"Diverse roles of TGF-\u03b2\/Smads in renal fibrosis and inflammation","volume":"7","author":"Lan","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"F1217","DOI":"10.1152\/ajprenal.00294.2016","article-title":"Solute transport and oxygen consumption along the nephrons: effects of na+ transport inhibitors","volume":"311","author":"Layton","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/s0140-6736(17)30788-2","article-title":"Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy","volume":"390","author":"Levin","year":"2017","journal-title":"Lancet"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e120","DOI":"10.1161\/circresaha.122.320184","article-title":"Faecalibacterium prausnitzii attenuates CKD via butyrate-renal GPR43 axis","volume":"131","author":"Li","year":"2022","journal-title":"Circ. Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrg3920","article-title":"Machine learning applications in genetics and genomics","volume":"16","author":"Libbrecht","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"B85","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby","year":"2002","journal-title":"Nature"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e0132589","DOI":"10.1371\/journal.pone.0132589","article-title":"Meta-analysis of the associations of p-Cresyl sulfate (PCS) and indoxyl sulfate (IS) with cardiovascular events and all-cause mortality in patients with chronic renal failure","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1681\/asn.2021060843","article-title":"Intestinal bacterial translocation contributes to diabetic kidney disease","volume":"33","author":"Linh","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"16836","DOI":"10.1073\/pnas.1415518111","article-title":"Synchronized renal tubular cell death involves ferroptosis","volume":"111","author":"Linkermann","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B89","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"L\u00f6fman","year":"2017","journal-title":"Eur. J. Heart Fail"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol. Dial. Transpl."},{"key":"B91","doi-asserted-by":"publisher","first-page":"592602","DOI":"10.3389\/fmed.2021.592602","article-title":"Uremic toxins in organ crosstalk","volume":"8","author":"Lowenstein","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"B92","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrendo.2014.171","article-title":"Branched-chain amino acids in metabolic signalling and insulin resistance","volume":"10","author":"Lynch","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.3390\/ijms23105354","article-title":"Short-chain fatty acids in chronic kidney disease: focus on inflammation and oxidative stress regulation","volume":"23","author":"Magliocca","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B95","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41577-024-01014-8","article-title":"Short-chain fatty acids: linking diet, the microbiome and immunity","volume":"24","author":"Mann","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/s0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"B98","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2215\/cjn.04610510","article-title":"Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease","volume":"6","author":"McIntyre","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B100","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41581-019-0172-1","article-title":"Intestinal microbiome and fitness in kidney disease","volume":"15","author":"Meijers","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/circheartfailure.111.963413","article-title":"Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function","volume":"5","author":"Metra","year":"2012","journal-title":"Circ. Heart Fail"},{"key":"B103","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/10715762.2018.1457217","article-title":"ROS and RNS signalling: adaptive redox switches through oxidative\/nitrosative protein modifications","volume":"52","author":"Moldogazieva","year":"2018","journal-title":"Free Radic. Res."},{"key":"B104","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/cr.2010.178","article-title":"Crosstalk of reactive oxygen species and NF-\u03baB signaling","volume":"21","author":"Morgan","year":"2011","journal-title":"Cell. Res."},{"key":"B105","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.jchf.2014.06.008","article-title":"The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial","volume":"2","author":"Mortensen","year":"2014","journal-title":"JACC Heart Fail"},{"key":"B106","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion - a position statement from the heart failure association of the european society of cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur. J. Heart Fail"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/bj20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B109","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1681\/asn.2012040373","article-title":"NADPH-Oxidase 4 protects against kidney fibrosis during chronic renal injury","volume":"23","author":"Nlandu Khodo","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1681\/asn.2018060609","article-title":"Indoxyl sulfate and p-Cresyl sulfate promote vascular calcification and associate with glucose intolerance","volume":"30","author":"Opdebeeck","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol. Rev."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B113","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B114","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1681\/asn.0000000000000294","article-title":"Renal mitochondrial ATP transporter ablation ameliorates obesity-induced CKD","volume":"35","author":"Permyakova","year":"2024","journal-title":"J. Am. Soc. Nephrol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","article-title":"Mitophagy and quality control mechanisms in mitochondrial maintenance","volume":"28","author":"Pickles","year":"2018","journal-title":"Curr. Biol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.3390\/biomedicines12102314","article-title":"Multifaceted impact of SGLT2 inhibitors in heart failure patients: exploring diverse mechanisms of action","volume":"12","author":"Piperis","year":"2024","journal-title":"Biomedicines"},{"key":"B117","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/nejm199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1124\/dmd.122.000858","article-title":"Regulation of nuclear receptors PXR and CAR by small molecules and signal crosstalk: roles in drug metabolism and beyond","volume":"51","author":"Poudel","year":"2023","journal-title":"Drug Metab. Dispos."},{"key":"B119","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/cir.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American heart association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B121","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/cvr\/cvr024","article-title":"Epigenetic mechanisms in diabetic vascular complications","volume":"90","author":"Reddy","year":"2011","journal-title":"Cardiovasc Res."},{"key":"B122","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"Reitsma","year":"2007","journal-title":"Pflugers Arch."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1681\/asn.2012101006","article-title":"A combined epidemiologic and metabolomic approach improves CKD prediction","volume":"24","author":"Rhee","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1093\/eurheartj\/ehz542","article-title":"Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1\u03b2 inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis","volume":"41","author":"Ridker","year":"2020","journal-title":"Eur. Heart J."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2215\/cjn.11901115","article-title":"Phosphate toxicity in CKD: the killer among us","volume":"11","author":"Ritter","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1038\/s41591-018-0128-1","article-title":"Development of a gut microbe-targeted nonlethal therapeutic to inhibit thrombosis potential","volume":"24","author":"Roberts","year":"2018","journal-title":"Nat. Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","article-title":"Cardiorenal syndrome","volume":"52","author":"Ronco","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2215\/cjn.00240605","article-title":"Acute kidney injury associated with cardiac surgery","volume":"1","author":"Rosner","year":"2006","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/ki.2012.439","article-title":"Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease","volume":"83","author":"Ruiz","year":"2013","journal-title":"Kidney Int."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B132","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1161\/01.Cir.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.bbamcr.2010.09.019","article-title":"Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network","volume":"1813","author":"Scarpulla","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"B134","doi-asserted-by":"publisher","first-page":"355","DOI":"10.34067\/kid.0004772020","article-title":"Proximal tubular oxidative metabolism in acute kidney injury and the transition to CKD","volume":"2","author":"Schaub","year":"2021","journal-title":"Kidney360"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1161\/circresaha.114.301621","article-title":"PCSK9: a key modulator of cardiovascular health","volume":"114","author":"Seidah","year":"2014","journal-title":"Circ. Res."},{"key":"B136","doi-asserted-by":"publisher","first-page":"31479","DOI":"10.1038\/srep31479","article-title":"Pancreas-enriched miRNAs are altered in the circulation of subjects with diabetes: a pilot cross-sectional study","volume":"6","author":"Seyhan","year":"2016","journal-title":"Sci. Rep."},{"key":"B137","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/circresaha.110.234914","article-title":"Arterial calcification in chronic kidney disease: key roles for calcium and phosphate","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ. Res."},{"key":"B138","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/sj.clpt.6100275","article-title":"Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics","volume":"83","author":"Shu","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"B139","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/j.1749-6632.2010.05627.x","article-title":"Animal and human studies with the mitochondria-targeted antioxidant MitoQ","volume":"1201","author":"Smith","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B140","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehu111","article-title":"Carbamylated low-density lipoprotein induces endothelial dysfunction","volume":"35","author":"Speer","year":"2014","journal-title":"Eur. Heart J."},{"key":"B141","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3727\/096368915x689622","article-title":"Clinical trials with mesenchymal stem cells: an update","volume":"25","author":"Squillaro","year":"2016","journal-title":"Cell. Transpl."},{"key":"B142","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1161\/circulationaha.105.567297","article-title":"Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications","volume":"113","author":"Steffel","year":"2006","journal-title":"Circulation"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/hh2401.101070","article-title":"Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers","volume":"89","author":"Steitz","year":"2001","journal-title":"Circ. Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2337\/diab.44.4.369","article-title":"Diabetes and cardiovascular disease. The \u201ccommon soil\u201d hypothesis","volume":"44","author":"Stern","year":"1995","journal-title":"Diabetes"},{"key":"B145","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3390\/nu10060773","article-title":"Dose-dependent effects of multispecies probiotic supplementation on the lipopolysaccharide (LPS) level and cardiometabolic profile in Obese postmenopausal women: a 12-Week randomized clinical trial","volume":"10","author":"Szuli\u0144ska","year":"2018","journal-title":"Nutrients"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/cpt.3029","article-title":"Development of 4-Pyridoxic acid PBPK model to support biomarker-informed evaluation of OAT1\/3 inhibition and effect of chronic kidney disease","volume":"114","author":"Tan","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"B148","doi-asserted-by":"publisher","first-page":"F1187","DOI":"10.1152\/ajprenal.00425.2014","article-title":"Hypoxia as a key player in the AKI-to-CKD transition","volume":"307","author":"Tanaka","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.kint.2016.09.015","article-title":"Cardiovascular events and death in Japanese patients with chronic kidney disease","volume":"91","author":"Tanaka","year":"2017","journal-title":"Kidney Int."},{"key":"B150","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/circresaha.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ. Res."},{"key":"B151","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41581-020-00369-0","article-title":"Mitochondrial quality control in kidney injury and repair","volume":"17","author":"Tang","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s12967-023-04455-2","article-title":"The gut microbiome tango in the progression of chronic kidney disease and potential therapeutic strategies","volume":"21","author":"Tang","year":"2023","journal-title":"J. Transl. Med."},{"key":"B153","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/nature17184","article-title":"PGC1\u03b1 drives NAD biosynthesis linking oxidative metabolism to renal protection","volume":"531","author":"Tran","year":"2016","journal-title":"Nature"},{"key":"B154","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/circresaha.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ. Res."},{"key":"B155","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nri2653","article-title":"Intestinal mucosal barrier function in health and disease","volume":"9","author":"Turner","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","article-title":"Molecular mechanisms and therapeutic targets for diabetic kidney disease","volume":"102","author":"Tuttle","year":"2022","journal-title":"Kidney Int."},{"key":"B157","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/s0140-6736(22)01429-5","article-title":"SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials","volume":"400","author":"Vaduganathan","year":"2022","journal-title":"Lancet"},{"key":"B158","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1080\/10590500902885684","article-title":"8-hydroxy-2' -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis","volume":"27","author":"Valavanidis","year":"2009","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"key":"B159","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41581-020-0256-y","article-title":"The tubular hypothesis of nephron filtration and diabetic kidney disease","volume":"16","author":"Vallon","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1681\/asn.2013101062","article-title":"The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"B161","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3390\/toxins10010033","article-title":"Biochemical and clinical impact of organic uremic retention solutes: a comprehensive update","volume":"10","author":"Vanholder","year":"2018","journal-title":"Toxins (Basel)"},{"key":"B162","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/apha.12646","article-title":"Endothelial dysfunction and vascular disease - a 30th anniversary update","volume":"219","author":"Vanhoutte","year":"2017","journal-title":"Acta Physiol. (Oxf)"},{"key":"B163","doi-asserted-by":"publisher","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences","volume":"290","author":"Vaziri","year":"2006","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1093\/ndt\/gfr624","article-title":"Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-Associated inflammation","volume":"27","author":"Vaziri","year":"2012","journal-title":"Nephrol. Dial. Transpl."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000345969","article-title":"Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease","volume":"37","author":"Vaziri","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1161\/atvbaha.108.183384","article-title":"Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition","volume":"29","author":"Villa-Bellosta","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis","volume":"55","author":"Vlachopoulos","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.3390\/jcm12051948","article-title":"Gut microbiota in chronic kidney disease: from composition to modulation towards better Outcomes-A systematic review","volume":"12","author":"Voroneanu","year":"2023","journal-title":"J. Clin. Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"B170","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes","volume":"17","author":"Wang","year":"2011","journal-title":"Nat. Med."},{"key":"B171","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/ki.2012.448","article-title":"-Cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int."},{"key":"B172","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrcardio.2012.158","article-title":"Myofibroblast-mediated mechanisms of pathological remodelling of the heart","volume":"10","author":"Weber","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/s0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"B174","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1097\/01.asn.0000123691.46138.e2","article-title":"Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies","volume":"15","author":"Weiner","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"B175","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1093\/cvr\/cvab263","article-title":"Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis","volume":"118","author":"Witkowski","year":"2022","journal-title":"Cardiovasc Res."},{"key":"B176","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J. Pathol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1681\/asn.2010080793","article-title":"Mechanisms of tubulointerstitial fibrosis","volume":"21","author":"Zeisberg","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"19305","DOI":"10.1038\/s41598-021-98437-3","article-title":"The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages","volume":"11","author":"Zeng","year":"2021","journal-title":"Sci. Rep."},{"key":"B179","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-smad pathways in TGF-Beta signaling","volume":"19","author":"Zhang","year":"2009","journal-title":"Cell. Res."},{"key":"B180","doi-asserted-by":"publisher","first-page":"e2400459","DOI":"10.1002\/ardp.202400459","article-title":"MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: a review of preclinical research and future directions","volume":"357","author":"Zheng","year":"2024","journal-title":"Arch. Pharm. Weinh."},{"key":"B181","doi-asserted-by":"publisher","first-page":"155194","DOI":"10.1016\/j.metabol.2022.155194","article-title":"Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming","volume":"131","author":"Zhu","year":"2022","journal-title":"Metabolism"},{"key":"B182","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B183","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1016\/s0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"B184","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-Induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1801502\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T07:22:43Z","timestamp":1783581763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1801502\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":184,"alternative-id":["10.3389\/fphar.2026.1801502"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1801502","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"1801502"}}